Therapeutic options for external genital warts.

Area of Science:

• Dermatology
• Virology
• Public Health

Background:

• External genital warts (EGWs) are a common manifestation of human papillomavirus (HPV) infection.
• Current treatments focus on lesion eradication, not viral clearance, leading to high recurrence rates.
• Recurrence can occur in 25-66% of cases within 3 months post-treatment.

Purpose of the Study:

• To review current treatment modalities for external genital warts.
• To discuss the advantages and disadvantages of provider- vs. patient-applied therapies.
• To emphasize the need for individualized treatment strategies for EGWs.

Main Methods:

• Review of existing literature on EGW treatments.
• Categorization of therapies into provider-applied and patient-applied options.
• Analysis of factors influencing treatment selection.

Main Results:

• Provider-applied therapies include cryotherapy, acids, electrocautery, surgery, and laser.
• Patient-applied options include topical imiquimod and sinecatechins (green tea extract).
• No single treatment is universally optimal; efficacy, cost, and side effects vary.

Conclusions:

• Treatment selection for EGWs requires a personalized approach.
• Patient preferences, lesion characteristics, and provider expertise guide optimal therapy choice.
• Tailored treatment plans are essential for managing EGWs effectively.